Gene · 4659
Papers1,922
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,922
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RBM25 Drives Hepatocellular Carcinoma Progression by Stabilizing YAP Through Regulating Oncogenic Splicing-switch of MYPT1. | Adv Sci (Weinh) | 2026 | 42750313 | PubTator, text mining | PubMed |
| The emerging function of MYPT1 as a biomarker and therapeutic target. | Folia Med (Plovdiv) | 2026 | 42677782 | PubTator, text mining | PubMed |
| Phenotypic Expansion of PPP1R12A-Related Syndrome: A Novel Splicing Variant Associated with Hearing Loss and Inner Ear Malformations. | Genes (Basel) | 2026 | 42650049 | PubTator, text mining | PubMed |
| PPM1B suppresses cervical carcinoma invasion by dephosphorylating MYPT1 at Thr853 and inactivating the PRMT5 epigenetic axis. | Eur J Cell Biol | 2026 | 42585950 | PubTator, text mining | PubMed |
| Determinants of protein phosphatase 1β substrate specificity for MyPhoNE motif-containing proteins. | J Biol Chem | 2026 | 42556723 | PubTator, text mining | PubMed |
| Morphological, Molecular and Motility Changes in Human Small Intestine After Loop Ileostomy. | J Neurogastroenterol Motil | 2026 | 42504660 | PubTator, text mining | PubMed |
| Small subunit M20 augments inhibitory phosphorylation of MYPT1 in myosin light chain phosphatase by inhibiting autodephosphorylation. | Proc Natl Acad Sci U S A | 2026 | 42485392 | PubTator, text mining | PubMed |
| Epigenome-wide association analysis of prenatal organophosphate ester flame retardant exposure in maternal blood implicates maternal immune and neuronal epigenetic alterations. | Environ Int | 2026 | 42424771 | PubTator, text mining | PubMed |
| Green Tea Polyphenol (-)-Epigallocatechin-3-gallate Protects Endothelial Barrier Function via Myosin Phosphatase and Rho-Kinase. | Int J Mol Sci | 2026 | 42352891 | PubTator, text mining | PubMed |
| Construction of an actin cytoskeleton-related gene signature for predicting prognosis and therapeutic response in glioblastoma: based on machine learning. | Transl Cancer Res | 2026 | 42180858 | PubTator, text mining | PubMed |
| Expanded Phenotype Associated With an Intronic PPP1R12A Variant: A Case Report and Literature Review. | Am J Med Genet A | 2026 | 42178607 | PubTator, text mining | PubMed |
| A Novel PPP1R12A Splice-Site Variant Identified in a Female Fetus With Perineal Hamartoma. | Prenat Diagn | 2026 | 42165277 | PubTator, text mining | PubMed |
| Erratum to: PPP1R12A mutation leads to different genders of twinning: a case report and literature review. | Transl Pediatr | 2026 | 42158649 | PubTator, text mining | PubMed |
| The Role of A-Kinase Anchoring Proteins for Inhibitory cAMP Signalling in Platelets. | Cells | 2026 | 41892342 | PubTator, text mining | PubMed |
| NUAK1 silencing enhances radiotherapy-induced ferroptosis in locally advanced rectal cancer by impairing Nrf2-driven transcription of GPX4. | Cell Oncol (Dordr) | 2026 | 41848996 | PubTator, text mining | PubMed |
| ROCK signaling at the crossroads of redox stress, mitochondrial dynamics, and metabolic disease. | Redox Biol | 2026 | 41791289 | PubTator, text mining | PubMed |
| Compressive stress-driven Piezo1 activation and Rho-ROCK mechanotransduction promote tumor progression via epigenetic mechanical memory. | Sci Adv | 2026 | 41779857 | PubTator, text mining | PubMed |
| Tumor-educated platelets: from molecular mechanisms to liquid biopsy and therapeutic applications. | Int J Pharm | 2026 | 41765057 | PubTator, text mining | PubMed |
| Molecular Health Effects of Electronic Cigarettes. | Biomolecules | 2026 | 41750334 | PubTator, text mining | PubMed |
| The Role of Actin-Binding Proteins in Breast Cancer Progression. | Breast Cancer (Dove Med Press) | 2026 | 41743193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4659/papers